A phase III trial of larazotide for celiac disease
Phase of Trial: Phase III
Latest Information Update: 28 Nov 2016
At a glance
- Drugs Larazotide (Primary)
- Indications Coeliac disease
- Focus Registrational; Therapeutic Use
- Sponsors Innovate Biopharmaceuticals
- 28 Nov 2016 This trial is expected to start in 2017, according to an Innovate Pharma media release.
- 03 Mar 2016 New trial record
- 29 Feb 2016 This trial is expected to begin in late 2016, according to an Innovate Pharma media release.